Lv1
48 积分 2025-03-13 加入
青光眼患者药物治疗依从性的临床调查研究
2个月前
已完结
Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials
4个月前
已完结
Pharmacokinetics, pharmacodynamics, and safety of subcutaneous anifrolumab in patients with systemic lupus erythematosus, active skin disease, and high type I interferon gene signature: a multicentre, randomised, double-blind, placebo-controlled, phase 2 study
4个月前
已完结
Combined gastric and colorectal cancer endoscopic screening may be cost-effective in Europe with the implementation of artificial intelligence: an economic evaluation
4个月前
已完结
Efficacy of belimumab in patients with systemic lupus erythematosus from North East Asia: Results of exploratory subgroup analyses
5个月前
已完结
Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus
5个月前
已完结
Response to telitacicept in systemic lupus erythematosus patients: a real‐world, single‐center observational study in China
5个月前
已完结
The effectiveness of telitacicept in patients with systemic lupus erythematosus: A retrospective, real-world study
5个月前
已完结
The efficacy and safety of telitacicept for the treatment of systemic lupus erythematosus: a real life observational study
5个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
7个月前
已完结
皖公网安备34019202002308
